Unlocking EV Biomarkers with Unparalleled Precision
Combining semiconductor-grade microfluidics and dielectrophoresis
Project overview
We partnered with the EXOKĒRYX team to translate their proprietary chip technology into a low-cost, scalable consumable and developed a fully automated platform tailored to their product and market needs—all while working seamlessly alongside their internal team.
Automated Platform Design
Scalable Consumable Development
Integrated Team Collaboration
Key Achievements
Delivering Diagnostic Innovation at Scale
Arete partnered with EXOKĒRYX to design a fully automated platform and cost-effective consumable around their proprietary chip—achieving performance, usability, and manufacturability targets while aligning seamlessly with their internal team.
Key Achievement
Designed and built a manufacturable, low-cost consumable and fully automated platform around EXOKĒRYX’s proprietary chip—all within a rapid development cycle of under one year—while meeting stringent usability, performance, and scalability goals.
Client Impact
Delivered a RUO-ready platform in under a year that met cost and performance targets by tightly integrating with EXOKĒRYX’s internal electrical team—reducing development time, controlling costs, and accelerating path to market.
.webp)
We’ve made rapid, high-quality progress and got a lot of value for our investment. I’ve already recommended Arete to others—and we’re planning to bring them into our next platform project. This is a partnership I want to continue for years to come.
Bryan Rice
President & CTO
